Table 1.
Baseline characteristics of patients undergoing cardiovascular magnetic resonance
| Medical group (n = 11) | PCI group (n = 12) | p Value | |
| Age (years) | 55.7 (10.4) | 58.3 (10.6) | 0.4 |
| Men | 100% | 100% | |
| Thrombolysis | 97% | 98% | 1.0 |
| Peak creatine kinase (U/l) | 1800 | 2400 | 0.7 |
| Risk factors | |||
| Diabetes | 27.3% | 30.8% | 0.6 |
| Hypertension | 45.5% | 23.1% | <0.001 |
| Dyslipidaemia | 27.3% | 30.8% | 0.6 |
| Smoker at time of MI | 36.4% | 46.2% | 0.2 |
| Post-MI treatment | |||
| Aspirin | 100% | 100% | |
| β Blockers | 90.9% | 92.3% | 1.0 |
| ACE inhibitors | 100% | 100% | |
| Statins | 100% | 100% | |
| Initial CMR | |||
| EDVI (ml) | 92 (26) | 98 (20) | 0.2 |
| ESVI (ml) | 53 (27) | 58 (24) | 0.5 |
| Ejection fraction (%) | 44 (14) | 43 (14) | 0.8 |
| LVMI (g/m2) | 72 (12) | 82 (18) | 0.1 |
| Screening angiogram | |||
| Time from MI to angiogram (days) | 36.7 (12.0) | 22.8 (16.2) | 0.9 |
| TIMI 0 flow | 63.6% | 91.7% | |
| TIMI 1 flow | 36.4% | 8.3% | |
| LVEDP (mm Hg) | 28.1 | 32.7 | 0.8 |
ACE, angiotensin converting enzyme; EDVI, end diastolic volume index; ESVI, end systolic volume index; LVEDP, left ventricular end diastolic pressure; LVMI, left ventricular mass index; MI, myocardial infarction; TIMI, thrombolysis in myocardial infarction.